Login / Signup
Basil Kopp
ORCID
Publication Activity (10 Years)
Years Active: 2021-2021
Publications (10 Years): 1
Top Topics
Allogeneic Hematopoietic Stem Cell Transplantation
Dna Methylation
Acute Myeloid Leukemia
Replacement Therapy
Top Venues
Cancers
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Katja Seipel
,
Basil Kopp
,
Vera Ulrike Bacher
,
Thomas Pabst
BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia.
Cancers
13 (3) (2021)